coronaviru
diseas
first
diagnos
wuhan
decemb
world
health
organ
defin
subsequ
outbreak
worldwid
public
health
emerg
intern
concern
epidemiolog
data
indic
least
patient
sever
diseas
addit
impair
respiratori
system
acut
kidney
injuri
aki
major
complic
immun
damag
mediat
cytokin
storm
concomit
aki
key
factor
poor
prognosi
base
previou
experi
blood
purif
patient
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
combin
clinic
frontlin
practic
develop
blood
purif
protocol
patient
sever
protocol
divid
four
major
step
first
step
assess
whether
patient
sever
requir
blood
purif
second
step
prescrib
blood
purif
treatment
patient
third
step
monitor
adjust
paramet
blood
purif
fourth
step
evalu
time
discontinu
blood
purif
expect
blood
purif
play
key
role
effect
reduc
mortal
patient
sever
standard
implement
present
protocol
coronaviru
name
world
health
organ
februari
origin
english
name
novel
coronaviru
pneumonia
revis
nation
health
commiss
china
februari
consist
name
although
chines
name
remain
unchang
far
case
confirm
china
accord
report
literatur
proport
patient
sever
critic
respect
overal
crude
case
fatal
rate
approxim
present
prevent
treatment
enter
critic
stage
effect
treatment
sever
critic
ill
patient
key
reduc
associ
mortal
diagnosi
treatment
protocol
novel
coronaviru
pneumonia
trial
sixth
edit
diagnosi
treatment
protocol
sever
critic
case
novel
coronaviru
pneumonia
trial
mention
addit
activ
oxygen
therapi
respiratori
support
circulatori
monitor
support
nutrit
support
treatment
occurr
acut
kidney
injuri
aki
multipl
organ
dysfunct
syndrom
mod
evalu
time
manner
critic
ill
patient
high
inflammatori
respons
plasma
purif
absorpt
perfus
bloodplasma
filtrat
blood
purif
techniqu
perform
possibl
excess
inflammatori
respons
sever
target
organ
involv
sever
depend
patient
immun
statu
target
organ
involv
excess
immun
respons
trigger
cytokin
storm
multipl
excess
inflammatori
respons
throughout
bodi
damag
multipl
target
organ
involv
clinic
studi
shown
concentr
serum
inflammatori
mediat
includ
interleukin
il
granulocyt
colonystimul
factor
interferoninduc
protein
monocyt
chemoattract
protein
macrophag
inflammatori
protein
tumor
necrosi
factor
tnfa
significantli
higher
sera
patient
sever
patient
mild
diseas
first
recent
report
patholog
anatomi
dead
patient
show
lung
diffus
alveolar
damag
fibromucos
exud
hyalin
membran
format
consist
acut
respiratori
distress
syndrom
ard
flow
cytometri
reveal
cell
count
peripher
blood
greatli
reduc
howev
doubl
high
posit
ratio
human
leukocyt
antigendr
confirm
simultan
exist
lymphocyt
hyperactiv
addit
number
highli
proinflammatori
cell
increas
cell
demonstr
high
cytotox
owe
excess
activ
prove
cytokin
stormmedi
immun
injuri
key
factor
lead
diseas
aggrav
poor
prognosi
lung
main
target
organ
report
incid
rate
ard
among
patient
rang
thu
requir
differ
degre
respiratori
support
studi
shown
protein
may
bind
angiotensinconvert
enzym
receptor
therebi
damag
target
organ
highli
express
kidney
nearli
time
higher
respiratori
tract
theoret
suggest
kidney
also
major
target
organ
data
clinic
studi
patient
includ
sever
case
show
patient
proteinuria
mild
moder
sever
patient
elev
urea
nitrogen
level
patient
elev
serum
creatinin
level
three
recent
publish
clinic
studi
show
incid
rate
aki
among
patient
patient
requir
continu
renal
replac
therapi
crrt
among
patient
incid
rate
aki
among
patient
sever
diseas
critic
ill
patient
admit
intens
care
unit
significantli
increas
rang
proport
patient
requir
crrt
e
rate
crrt
among
patient
aki
high
medic
evid
indic
aki
uncommon
among
patient
particularli
among
sever
diseas
therefor
treatment
patient
prompt
screen
aki
risk
factor
routin
dynam
monitor
urin
urin
sensit
kidney
function
serum
creatinin
daili
assess
aki
complic
optim
volum
hemodynam
use
nephrotox
drug
avoid
whenev
possibl
earli
blood
purif
intervent
perform
reduc
occurr
progress
aki
basic
principl
blood
purif
treatment
patient
sever
blood
purif
techniqu
includ
crrt
blood
plasma
perfus
absorpt
plasma
replac
mode
comprehens
blood
purif
basic
principl
blood
purif
treatment
patient
sever
mainli
includ
follow
remov
metabol
product
creatinin
urea
nitrogen
remov
variou
inflammatori
mediat
convect
absorpt
plasma
replac
reshap
immun
homeostasi
regul
volum
correct
fluid
overload
help
maintain
hemodynam
stabil
critic
ill
patient
correct
electrolyt
acidbas
balanc
disord
maintain
intern
environ
stabil
control
high
fever
combin
treatment
extracorpor
membran
oxygen
ecmo
extracorpor
multipl
organ
support
base
principl
intern
renown
critic
care
expert
claudio
ronco
jean
loui
vincent
jointli
publish
expert
review
titl
coronaviru
epidem
prepar
extracorpor
organ
support
intens
care
focu
column
lancet
respiratori
medicin
emphas
posit
blood
purif
treatment
sever
crrt
commonli
use
blood
purif
method
clinic
practic
patient
sever
sepsi
ard
blood
perfusionplasma
absorpt
treatment
also
select
elimin
inflammatori
medium
base
experi
perform
blood
purif
patient
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
combin
firstlin
clinic
practic
blood
purif
treatment
patient
sever
formul
process
blood
purif
treatment
patient
sever
process
divid
four
major
step
first
step
assess
whether
patient
sever
requir
blood
purif
second
step
prescrib
blood
purif
treatment
modal
patient
sever
third
step
monitor
manag
adjust
paramet
blood
purif
treatment
patient
sever
fourth
step
involv
downtim
evalu
blood
purif
detail
process
provid
fig
step
evalu
whether
patient
sever
requir
blood
purif
step
mainli
involv
assess
presenc
absenc
indic
contraind
time
implement
mediat
level
patient
sever
reach
five
time
upper
limit
normal
increas
time
within
hour
clinic
practic
physician
charg
comprehens
evalu
system
inflammatori
respons
sever
progress
diseas
sever
comorbid
aki
progress
aki
among
patient
consid
local
medic
resourc
qualif
blood
purif
oper
make
reason
choic
step
prescrib
blood
purif
treatment
patient
sever
prescript
blood
purif
treatment
patient
sever
must
formul
accord
need
patient
physiolog
goal
specif
content
includ
choic
mode
blood
purif
treatment
establish
vascular
access
choic
blood
purif
filter
anticoagul
scheme
treatment
dose
initi
paramet
set
inflammatori
mediat
recommend
filter
absorpt
properti
membran
oxiri
membran
select
high
molecular
weight
cutoff
filter
membran
pore
size
nm
approxim
time
pore
size
ordinari
highthroughput
membran
also
use
howev
filter
increas
remov
albumin
larg
molecul
monitor
supplement
time
recommend
local
citric
acid
anticoagul
scheme
follow
trisodium
citrat
solut
continu
administ
dose
time
blood
flow
rate
mlmin
filter
appli
citrat
concentr
reach
mmoll
filter
appli
free
calcium
concentr
filter
appli
maintain
mmoll
venou
free
calcium
concentr
maintain
mmoll
dose
citric
acid
adjust
accord
ioniz
calcium
concentr
filter
dose
calcium
chlorid
calcium
glucon
solut
adjust
accord
serum
concentr
ioniz
calcium
patient
contraind
citric
acid
contraind
argatroban
argatroban
use
anticoagul
continu
infus
mg
kg
min
filter
exact
first
dose
mgkg
administ
control
aptt
inr
blood
sampl
obtain
peripher
vein
arteri
end
crrt
line
less
time
base
valu
aptt
inr
blood
sampl
obtain
venou
end
crrt
line
maintain
time
base
valu
patient
contraind
use
argatroban
heparin
use
local
anticoagul
prefil
filter
l
normal
salin
u
plain
heparin
initi
dose
plain
heparin
ukg
follow
uh
arteri
input
protamin
administ
via
venou
end
initi
ratio
mg
protamin
u
heparin
adjust
ratio
heparin
protamin
accord
aptt
bodi
circul
circuit
keep
aptt
bodi
within
normal
rang
aptt
circul
circuit
time
normal
valu
anticoagul
combin
ecmo
ecmo
mainli
use
system
heparin
main
anticoagul
method
thu
necessari
administ
anticoagul
crrt
treatment
dose
paramet
set
crrt
kdigo
aki
guidelin
recommend
patient
treat
crrt
therapeut
dose
ml
kg
h
use
postdilut
ml
kg
h
use
predilut
use
hvhf
remov
inflammatori
mediat
recommend
dose
ml
kg
h
scuf
use
ultrafiltr
rate
gener
set
ml
min
adjust
time
accord
patient
volum
statu
hemodynam
stabil
principl
total
amount
scuf
ultrafiltr
exceed
l
unit
bodi
weight
kg
durat
treatment
hour
begin
treatment
blood
flow
rate
gener
increas
gradual
ml
min
mlmin
separ
plasma
flow
absorpt
column
flow
rate
mlmin
return
bodi
step
patient
monitor
paramet
adjust
blood
purif
treatment
sever
blood
purif
treatment
patient
sever
patient
monitor
strengthen
treatment
paramet
adjust
accord
monitor
content
titrat
electrolyt
acidbas
balanc
monitor
blood
level
potassium
sodium
bicarbon
measur
everi
hour
crrt
blood
level
magnesium
phosphoru
measur
least
everi
hour
replac
fluid
dialys
formula
adjust
time
accord
test
result
anticoagul
index
monitor
monitor
differ
indic
accord
differ
anticoagul
method
see
anticoagul
scheme
detail
anticoagul
mainli
check
coagul
filter
help
judgment
base
transmembran
pressur
filter
front
pressur
pulmonari
imag
monitor
patient
sever
show
rapid
chang
lung
imag
recommend
chest
radiograph
lung
comput
tomographi
imag
monitor
least
everi
day
determin
efficaci
step
downtim
evalu
blood
purif
patient
sever
consensu
regard
indic
downtim
blood
purif
treatment
patient
sever
downtim
recommend
follow
situat
downtim
crrt
patient
vital
sign
stabl
hemodynam
normal
ventil
condit
significantli
reduc
water
electrolyt
acidbas
balanc
disord
correct
daili
urin
output
without
diuret
ml
diuret
ml
downtim
plasma
exchang
plasma
perfusionabsorpt
perform
system
inflammatori
respons
syndrom
improv
respiratori
function
improv
acut
liver
failur
obvious
correct
level
serum
inflammatori
mediat
drop
less
twice
normal
valu
final
emphas
medic
personnel
must
protect
disinfect
blood
purif
equip
venu
perform
blood
purif
treatment
patient
none
april
